Privia Health Group, Inc. (PRVA)
NASDAQ: PRVA · Real-Time Price · USD
25.57
+1.04 (4.24%)
At close: Jun 26, 2026, 4:00 PM EDT
26.00
+0.43 (1.68%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Privia Health Group Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Privia Health Group stock have an average target of 31.38, with a low estimate of 24 and a high estimate of 36. The average target predicts an increase of 22.72% from the current stock price of 25.57.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Privia Health Group stock from 20 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 13 | 14 | 14 | 14 | 13 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 20 | 21 | 21 | 21 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Buy Maintains $33 | Buy | Maintains | $33 | +29.06% | Jun 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $34 | Buy | Maintains | $34 | +32.97% | May 28, 2026 |
| Barclays | Barclays | Hold Maintains $25 → $24 | Hold | Maintains | $25 → $24 | -6.14% | May 26, 2026 |
| Citi | Citi | Buy Maintains $32 | Buy | Maintains | $32 | +25.15% | May 14, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $30 | Buy | Maintains | $30 | +17.32% | May 11, 2026 |
Financial Forecast
Revenue This Year
2.43B
from 2.12B
Increased by 14.26%
Revenue Next Year
2.66B
from 2.43B
Increased by 9.85%
EPS This Year
0.95
from 0.99
Decreased by -3.82%
EPS Next Year
1.10
from 0.95
Increased by 15.24%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.5B | 2.9B | |
| Avg | 2.4B | 2.7B | |
| Low | 2.4B | 2.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 18.1% | 18.9% | |
| Avg | 14.3% | 9.8% | |
| Low | 12.1% | 5.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.20 | 1.41 | |
| Avg | 0.95 | 1.10 | |
| Low | 0.74 | 0.73 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.2% | 48.1% | |
| Avg | -3.8% | 15.2% | |
| Low | -25.3% | -23.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.